COMPOSITION PHARMACEUTIQUE PULVERISEE A SEC RENFERMANT DU N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N'-{4-[7-(2-MORPHOLIN-4-YL-ETHOXY)IMIDAZE[2,1-B][1,3]BENZOTHIAZOL-2-YL]PHENYL}UREE

• 收藏
• 分享

专利权人:

AMBIT BIOSCIENCES CORPORATION

发明人:

CORRINGHAM, ROBERT E.,O'DONNELL, PATRICK B.,JAMES, JOYCE K.

申请号：

CA2761940

公开号：

CA2761940C

申请日:

2010.05.14

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

Provided herein are methods of administeringN-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7- (2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt orsolvate thereof, to humanpatients, including a specific patient population. Specifically, dosing,dosing schedules or dosing regimens are provided herein.Methods of treating proliferative diseases or FLT-3 mediated diseases inhumans are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/